CIK: 0001697013
Total reported value
$1.9B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | VERA | Vera Therapeutics INC | Stock-Other | 7.84% | -3.23% | +9.42% | |
| 2 | QQQ | Invesco Qqq Trust Series 1 | ETF-Tech | 6.97% | — | -2.17% | |
| 3 | GSK | Gsk Plc-spon Adr | Stock-Healthcare | 6.62% | -1.42% | +26.38% | |
| 4 | UTHR | United Therapeutics CORP | Stock-Healthcare | 6.20% | +2.06% | -6.25% | |
| 5 | ABVX | Abivax Sa-adr | Stock-Other | 4.47% | +1.02% | +54.24% | |
| 6 | NTRA | Natera INC | Stock-Healthcare | 3.86% | — | -35.63% | |
| 7 | SNDX | Syndax Pharmaceuticals INC | Stock-Other | 3.51% | — | -4.41% | |
| 8 | VRDN | Viridian Therapeutics INC | Stock-Other | 2.79% | -2.05% | -7.38% | |
| 9 | PCVX | Vaxcyte INC | Stock-Other | 2.78% | — | -15.77% | |
| 10 | TVTX | Travere Therapeutics INC | Stock-Other | 2.26% | -1.41% | -17.09% | |
| 11 | HCA | Hca Healthcare INC | Stock-Healthcare | 2.26% | — | -14.17% | |
| 12 | DHR | Danaher CORP | Stock-Healthcare | 2.15% | -2.15% | EXIT | |
| 13 | IONS | Ionis Pharmaceuticals INC | Stock-Healthcare | 2.15% | — | -0.08% | |
| 14 | CLDX | Celldex Therapeutics INC | Stock-Other | 1.96% | +1.03% | +24.33% | |
| 15 | BRKR | Bruker CORP | Stock-Healthcare | 1.86% | -1.64% | +14.07% | |
| 16 | AVTR | Avantor INC | Stock-Healthcare | 1.83% | -0.60% | +243.63% | |
| 17 | SPY | Ss Spdr S&p 500 ETF Trust-us | ETF-Large Cap & Growth | 1.54% | +2.13% | — | |
| 18 | CYH | Community Health Systems INC | Stock-Other | 1.25% | — | +14.30% | |
| 19 | EXK | Exact Sciences CORP | Stock-Materials | 1.24% | -1.24% | EXIT | |
| 20 | BCRX | Biocryst Pharmaceuticals INC | Stock-Other | 1.18% | — | +117.88% | |
| 21 | GERN | Geron CORP | Stock-Other | 1.17% | — | +40.17% | |
| 22 | TECH | Bio-techne CORP | Stock-Healthcare | 1.12% | -0.77% | -36.20% | |
| 23 | CDTX | Cidara Therapeutics INC | Stock-Other | 1.10% | -1.10% | EXIT | |
| 24 | PODD | Insulet CORP | Stock-Healthcare | 1.07% | +0.52% | +63.82% | |
| 25 | BBNX | Beta Bionics INC | Stock-Other | 1.04% | — | — | |
| 26 | TEVA | Teva Pharmaceutical-sp Adr | Stock-Healthcare | 1.04% | -1.04% | EXIT | |
| 27 | UNH | Unitedhealth Group INC | Stock-Healthcare | 1.01% | -0.44% | -3.12% | |
| 28 | TLT | Ishares 20+ Year Treasury Bd | ETF-Gov Bonds | 1.01% | +0.95% | — | |
| 29 | LQDA | Liquidia CORP | Stock-Other | 0.89% | — | +4.82% | |
| 30 | ICLR | ICON Public Limited Company | Stock-Healthcare | 0.88% | -0.48% | +74.16% | |
| 31 | HQY | Healthequity INC | Stock-Healthcare | 0.86% | -0.63% | +254.54% | |
| 32 | GKOS | Glaukos CORP | Stock-Healthcare | 0.84% | -0.50% | — | |
| 33 | RVTY | Revvity INC | Stock-Healthcare | 0.79% | -0.40% | -58.72% | |
| 34 | NAMS | NewAmsterdam Pharma Company N.V. | Stock-Other | 0.74% | — | -13.87% | |
| 35 | ESPR | Esperion Therapeutics INC | Stock-Other | 0.72% | -0.47% | — | |
| 36 | BIIB | Biogen INC | Stock-Healthcare | 0.69% | -0.69% | EXIT | |
| 37 | SEM | Select Medical Holdings CORP | Stock-Other | 0.68% | -0.68% | EXIT | |
| 38 | CNC | Centene CORP | Stock-Healthcare | 0.67% | -0.48% | +44.33% | |
| 39 | CGON | Cg Oncology INC | Stock-Other | 0.65% | -0.65% | EXIT | |
| 40 | BMY | Bristol-myers Squibb Co | Stock-Healthcare | 0.64% | -0.64% | EXIT | |
| 41 | PALI | Palisade Bio INC | Stock-Other | 0.64% | — | — | |
| 42 | ARQT | Arcutis Biotherapeutics INC | Stock-Other | 0.64% | — | +289.93% | |
| 43 | PHVS | Pharvaris N.V. | Stock-Other | 0.61% | — | — | |
| 44 | XBI | Ss Spdr S&p Biotech ETF | ETF-Tech | 0.61% | -0.41% | — | |
| 45 | LLY | Eli Lilly & Co | Stock-Healthcare | 0.58% | — | — | |
| 46 | EHC | Encompass Health CORP | Stock-Healthcare | 0.57% | — | — | |
| 47 | CTMX | Cytomx Therapeutics INC | Stock-Other | 0.54% | — | — | |
| 48 | ELV | Elevance Health INC | Stock-Healthcare | 0.53% | -0.53% | EXIT | |
| 49 | MNKD | Mannkind CORP | Stock-Other | 0.53% | -0.53% | EXIT | |
| 50 | XENE | Xenon Pharmaceuticals INC | Stock-Other | 0.52% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | VERA | Vera Therapeutics INC | +2.2% | +9.42% | Add |
| 2 | ABVX | Abivax Sa-adr | +2% | +54.24% | Add |
| 3 | AVTR | Avantor INC | +1% | +243.63% | Add |
| 4 | DHR | Danaher CORP | +0.8% | +87.63% | Add |
| 5 | HQY | Healthequity INC | +0.5% | +254.54% | Add |
| 6 | ARQT | Arcutis Biotherapeutics INC | +0.5% | +289.93% | Add |
| 7 | BCRX | Biocryst Pharmaceuticals INC | +0.5% | +117.88% | Add |
| 8 | PNTG | Pennant Group Inc/the | +0.4% | +673.99% | Add |
| 9 | BRKR | Bruker CORP | +0.3% | +14.07% | Add |
| 10 | GSK | Gsk Plc-spon Adr | +0.3% | +26.38% | Add |
| 11 | ICLR | ICON Public Limited Company | +0.2% | +74.16% | Add |
| 12 | LQDA | Liquidia CORP | +0.1% | +4.82% | Add |
| 13 | PODD | Insulet CORP | +0.1% | +63.82% | Add |
| 14 | VRDN | Viridian Therapeutics INC | -0.1% | -7.38% | Trim |
| 15 | TVTX | Travere Therapeutics INC | -0.1% | -17.09% | Trim |
| 16 | CLDX | Celldex Therapeutics INC | -0.1% | +24.33% | Add |
| 17 | SNDX | Syndax Pharmaceuticals INC | -0.2% | -4.41% | Trim |
| 18 | IONS | Ionis Pharmaceuticals INC | -0.3% | -0.08% | Trim |
| 19 | EOLS | Evolus INC | -0.5% | -76.67% | Trim |
| 20 | SPRY | Ars Pharmaceuticals INC | -0.5% | -74.24% | Trim |
| 21 | TEVA | Teva Pharmaceutical-sp Adr | -0.9% | -51.59% | Trim |
| 22 | TECH | Bio-techne CORP | -1.2% | -36.20% | Trim |
| 23 | UTHR | United Therapeutics CORP | -1.6% | -6.25% | Trim |
| 24 | RVTY | Revvity INC | -1.6% | -58.72% | Trim |
| 25 | NTRA | Natera INC | -1.9% | -35.63% | Trim |
| 26 | QURE | uniQure N.V. | -3.5% | -92.84% | Trim |
| 27 | ZIMV | Zimvie INC | — | EXIT | Sold out |
| 28 | SPY | Ss Spdr S&p 500 ETF Trust-us | — | NEW | New buy |
| 29 | EXK | Exact Sciences CORP | — | NEW | New buy |
| 30 | CDTX | Cidara Therapeutics INC | — | NEW | New buy |
| 31 | BBNX | Beta Bionics INC | — | NEW | New buy |
| 32 | TLT | Ishares 20+ Year Treasury Bd | — | NEW | New buy |
| 33 | GKOS | Glaukos CORP | — | NEW | New buy |
| 34 | ESPR | Esperion Therapeutics INC | — | NEW | New buy |
| 35 | RGEN | Repligen CORP | — | EXIT | Sold out |
| 36 | SEM | Select Medical Holdings CORP | — | NEW | New buy |
| 37 | RNAGBP | Avidity Biosciences INC | — | EXIT | Sold out |
| 38 | CGON | Cg Oncology INC | — | NEW | New buy |
| 39 | BMY | Bristol-myers Squibb Co | — | NEW | New buy |
| 40 | PALI | Palisade Bio INC | — | NEW | New buy |
| 41 | PHVS | Pharvaris N.V. | — | NEW | New buy |
| 42 | XBI | Ss Spdr S&p Biotech ETF | — | NEW | New buy |
| 43 | NVO | Novo-nordisk A/s-spons Adr | — | EXIT | Sold out |
| 44 | LLY | Eli Lilly & Co | — | NEW | New buy |
| 45 | EHC | Encompass Health CORP | — | NEW | New buy |
| 46 | CTMX | Cytomx Therapeutics INC | — | NEW | New buy |
| 47 | XENE | Xenon Pharmaceuticals INC | — | NEW | New buy |
| 48 | ASND | Ascendis Pharma A/S | — | NEW | New buy |
| 49 | MRNA | Moderna INC | — | NEW | New buy |
| 50 | RARE | Ultragenyx Pharmaceutical In | — | NEW | New buy |